Arkolith/Insider Trading/MLTX/Form 4

Santos da Silva Jorge

Chief Executive Officer, DirectorMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Oct 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2023Conversion(C)140K——3.2M
Oct 1, 2023Disposed to issuer(D)3.0M——0
Oct 1, 2023Conversion(C)3.0M——3.0M
Oct 1, 2023Disposed to issuer(D)140K——217K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2023Conversion(C)90K——0
Oct 1, 2023Conversion(C)4K——6K

Transaction Codes

C
Conversion of a derivative
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001013762-23-001297) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML